COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 577-583

  Parikh, Raj ^a   Shah, Trushil G ^a   Tandon, Rajive ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute exacerbation of chronic obstructive lung disease; Care bundle; COPD

Indexed keywords

ANTIBIOTIC AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; SALBUTAMOL;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE EXACERBATION; EARLY INTERVENTION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; ICD-9; INHALER; INTERMETHOD COMPARISON; LENGTH OF STAY; MALE; MIDDLE AGED; MORBIDITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PULMONOLOGIST; STANDARDIZATION; TERTIARY CARE CENTER; CARE BUNDLE; CASE CONTROL STUDY; DISEASE COURSE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STANDARDS; STATISTICS AND NUMERICAL DATA;

CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT CARE BUNDLES; PATIENT READMISSION; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STANDARD OF CARE;

EID: 84961775775     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S100401     Document Type: Article

References (42)

1. Hoyert DL, Xu JQ. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012;61(6):1-65.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
3. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(2):398S-401S.
4. Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration. 2012;84(1):17-26.
5. Blanchette CM, Gross NJ, Altman P. Rising costs of COPD and the potential for maintenance therapy to slow the trend. Am Health Drug Benefits. 2014;7(2):98-106.
6. Herse F, Kiljander T, Lehtimäki L. Annual costs of chronic obstructive pulmonary disease in Finland during 1996-2006 and a prediction model for 2007-2030. NPJ Prim Care Respir Med. 2015;26(25):15015.
7. Jansson SA, Backman H, Stenling A, Lindberg A, Ronmark E, Lundback B. Health economic costs of COPD in Sweden by disease severity-has it changed during a ten years period? Respir Med. 2013;107:1931-1938.
8. Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals’ FTE resident caps for graduate medical education payment. Final rules. Fed Regist. 2011;76(160):51476-51846.
9. Dalal AA, Shah M, D’Souza AO, Rane P. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med. 2011;105(3):454-460.
10. Lima FV, Yen TY, Patel JK. Trends in in-hospital outcomes among adults hospitalized with exacerbation of chronic obstructive pulmonary disease. COPD. 2015;12(6):636-642.
11. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418-1428.
12. Westert GP, Lagoe RJ, Keskimaki I, Leyland A, Murphy M. An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy. 2002;61:269-278.
13. Yu TC, Zhou H, Suh K, Arcona S. Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease. Clinicoecon Outcomes Res. 2015;7:37-51.
14. Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551-559.
15. Liu D, Peng SH, Zhang J, Bai SH, Liu HX, Qu JM. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;2(10):1265-1273.
16. Glaser JB, El-Haddad H. Exploring novel Medicare readmission risk variables in chronic obstructive pulmonary disease patients at high risk of readmission within 30 days of hospital discharge. Ann Am Thorac Soc. 2015;12(9):1288-1293.
17. Candrilli SD, Dhamane AD, Meyers JL, Kaila S. Factors associated with inpatient readmission among managed care enrollees with COPD. Hosp Pract (1995). 2015;43(4):199-207.
18. GOLD. Global strategy for diagnosis, management, and prevention of COPD. From the Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015. http://www.goldcopd.org. Accessed October 1, 2015.
19. Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, FitzGerald JM. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102:413-421.
20. Johnston NW, McIvor A, Lambert K, et al. The Christmas season as a risk factor for chronic obstructive pulmonary disease exacerbations. Can Respir J. 2010;17:275-281.
21. Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol. 2006;47:2554-2560.
22. Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235-245.
23. Amarasingham R, Plantinga L, Diener-West M, Gaskin DJ, Powe NR. Clinical information technologies and inpatient outcomes: a multiple hospital study. Arch Intern Med. 2009;169(2):108-114.
24. Mayorga CA, Rockey DC. Clinical utility of a standardized electronic order set for the management of acute upper gastrointestinal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol. 2013;11(10):1342-1348.
25. Ballard DJ, Ogola G, Fleming NS, et al. The impact of standardized order sets on quality and financial outcomes. In: Henriksen K, Battles JB, Keyes MA, et al, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 2: Culture and Redesign). Rockville, MD: Agency for Healthcare Research and Quality (US); 2008.
26. Ballard DJ, Ogola G, Fleming NS, et al. Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care. Int J Qual Health Care. 2010;22(6):437-444.
27. Meleskie J, Eby D. Adaptation and implementation of standardized order sets in a network of multi-hospital corporations in rural Ontario. Healthc Q. 2009;12(1):78-83.
28. Reingold S, Kulstad E. Impact of human factor design on the use of order sets in the treatment of congestive heart failure. Acad Emerg Med. 2007;14(11):1097-1105.
29. Micek S, Roubinian N, Heauring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med. 2006;34(11):2707-2713.
30. O’Connor C, DeCaire K, Friedrich J. Improving patient care through the use of evidence based order sets. AMIA Annu Symp Proc. 2005:1063.
31. Ozdas A, Speroff T, Waitman LR, Ozbolt J, Butler J, Miller RA. Integrating ‘best of care’ protocols into clinicians’ workflow via care provider order entry: impact on quality-of-care indicators for acute myocardial infarction. J Am Med Inform Assoc. 2006;13(2):188-196.
32. Santolin CJ, Boyer LS. Change of care for patients with acute myocardial infarctions through algorithm and standardized physician order sets. Crit Pathw Cardiol. 2004;3(2):79-82.
33. Takegami K, Kawaguchi Y, Nakayama H, Kubota Y, Nagawa H. Impact of a clinical pathway and standardization of treatment for acute appendicitis. Surg Today. 2003;33(5):336-341.
34. Kiyama T, Tajiri T, Yoshiyuki T, et al. Clinical significance of a standardized clinical pathway in gastrectomy patients. J Nippon Med Sch. 2003;70(3):263-269.
35. Panella M, Marchisio S, Di Stanislao F. Reducing clinical variations with clinical pathways: do pathways work? Int J Qual Health Care. 2003;15(6):509-521.
36. Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015;147(4):894-942.
37. Dunne PJ. A new imperative for respiratory therapists in COPD care. Presented at: Hoag Annual Respiratory Care Conference; October 2012; New Port Beach, CA.
38. Brown GL, Dunne PJ. COPD in-patient care: time for a new paradigm. AARC Times. 2011;35(11):34.
39. Hopkinson NS, Englebretsen C, Cooley N, et al. Designing and implementing a COPD discharge care bundle. Thorax. 2012;67:90-92.
40. Shah T, Churpek MM, Coca Perraillon M, Konetzka RT. Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion. Chest. 2015;147(5):1219-1226.
41. Turner AM, Lim WS, Rodrigo C, Welham SA, Calvert JM. A care-bundles approach to improving standard of care in AECOPD admissions: results of a national project. Thorax. 2015;70(10):992.
42. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397-412.